The Latest in Non-Hodgkin Lymphoma

AEs prompt EMA review of idelalisib

March 13, 2016

Allele associated with poor outcome in CLL

March 11, 2016

FDA lifts partial clinical hold on pidilizumab

March 10, 2016

FDA approves ibrutinib as first-line CLL therapy

March 5, 2016

FDA approves obinutuzumab for FL

February 27, 2016

AAs have lower rate of most blood cancers than NHWs

February 26, 2016

Orphan designation recommended for BTK inhibitor

February 26, 2016

How an anticancer drug fights lymphoid malignancies

February 23, 2016

Teens’ weight, height linked to risk of NHL

February 22, 2016

Drug shows promise for treating resistant AML, MCL

February 17, 2016

Combo can produce durable remissions in PTCL

February 12, 2016

Chemo regimen can be ‘highly effective’ against ENKTL

February 10, 2016

Dual inhibitor could treat ATLL

February 9, 2016

Immunotherapy proves active against MF, SS

February 5, 2016

Mutations may impact response to HDACis in PTCL-NOS

February 4, 2016